The RABBIT registry is supported by a joint, unconditional grant from AbbVie, Alfasigma, Amgen, Biocon, Bristol Myers Squibb, ...

CK Wang, MD, chief medical officer of COTA, discusses how real-world data help identify disparities and gaps in cancer care.

UNDATED (WKRC) - Weight-loss medications may not be as effective in "real-world" settings as they are in clinical trials, ...

Two medications used to treat type-2 diabetes and chronic weight management have been found to produce a smaller weight-loss ...

The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for ...

Research reveals major gap between weight-loss surgery and GLP-1 drugs, with real-world results of injectable medications falling short of clinical trial outcomes.

A panelist discusses how real-world experience with ruxolitinib and belumosidil shows similar response rates to clinical ...

In CNS research, where qualitative endpoint variability can significantly affect a trial’s outcome, the role of eCOA is ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

The U.S. opioid crisis has entered a new phase. With a 24% decline in overdose deaths between September 2023 and 2024 (CDC, ...

China's growing biotech prowess has become a real threat to the industry in the US in recent years. Moves by the Trump administration could weaken the US market further, according to several experts ...